Scientific trials on mixed use of Sputnik V, AstraZeneca vaccines begin
BAKU, Azerbaijan, Feb. 20
Scientific trials of the mixed use of COVID-19 vaccines – Russian Sputnik V and UK’s AstraZeneca have been began, the assertion on the official Twitter web page of Sputnik V vaccine stated, Development studies on Feb.20.
In response to the assertion, the immunity fashioned after the primary shot of AstraZeneca vaccine reduces the efficacy of its second dose (55 %), so the second shot should be made no sooner than three months after the primary one.
To unravel this downside, it was supplied to make use of the Russian vaccine because the second shot.
Earlier the Azerbaijani Well being Ministry gave permission to conduct clinicals trials on mixed use of the Sputnik V vaccine and a vaccine developed by AstraZeneca firm in cooperation with the College of Oxford. In Azerbaijan, these trials will begin by the tip of February 2021.